Filter
3406
Filtered Results: 3406
Text search:
Treated
prevalence
Featured
Recommendations
289
New Publications
1018
Language
Document type
No document type
2291
Studies & Reports
504
Guidelines
333
Manuals
107
Strategic & Response Plan
77
Training Material
34
Fact sheets
31
Situation Updates
13
Infographics
11
Resource Platforms
5
Countries / Regions
India
211
Kenya
115
Global
113
Western and Central Europe
90
South Africa
80
Nepal
79
Ethiopia
76
Uganda
73
Malawi
71
Sierra Leone
69
Tanzania
66
Nigeria
61
Rwanda
57
Liberia
55
Bangladesh
51
Zambia
51
Ghana
49
Africa
42
Latin America and the Carribbean
42
Eastern Europe
42
Myanmar / Burma
38
Namibia
36
Ukraine
31
Philippines
31
Lesotho
29
Cambodia
26
Zimbabwe
23
Mozambique
23
Syria
21
Senegal
21
Indonesia
21
Burkina Faso
20
Asia
20
South–East Asia Region
19
Botswana
19
Russia
16
South Sudan
16
Congo, Democratic Republic of
15
Eswatini/ Swaziland
14
Haiti
13
West and Central Africa
11
Brazil
11
Cameroon
10
Eastern Europe and Central Asia
10
East and Southern Africa
10
Venezuela
9
Albania
8
Afghanistan
8
Middle East and North Africa
8
Colombia
7
Benin
7
Peru
7
Tajikistan
6
Guinea
6
Germany
6
Sudan
6
Yemen
6
Madagascar
6
Pakistan
6
USA
5
North America
5
Southern Africa
5
Argentina
5
Georgia
5
Thailand
4
Jordan
4
Egypt
4
Iraq
4
North Macedonia
3
China
3
Armenia
3
Paraguay
3
Lebanon
3
Papua New Guinea
3
Moldova
3
Sri Lanka
3
Somalia
3
Timor Leste/ East Timor
2
Serbia
2
Gambia
2
Chile
2
Iran
2
Burundi
2
Qatar
2
Western Pacific Region
2
Jamaica
2
United Kingdom
2
Bolivia
2
Vietnam
2
Greece
2
Palestine
2
Central African Republic
2
Angola
2
Ecuador
2
Switzerland
1
El Salvador
1
Turkey
1
Canada
1
Singapore
1
Laos
1
Estonia
1
Niger
1
Uzbekistan
1
Mongolia
1
Dominican Republic
1
Guinea-Bissau
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Mauritius
1
Azerbaijan
1
Belarus
1
Djibouti
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1460
Clinical Guidelines
337
Public Health
202
Women & Child Health
178
Key Resources
83
Capacity Building
50
Pharmacy & Technologies
30
Toolboxes
TB
352
HIV
310
Mental Health
303
NTDs
135
Disability
115
AMR
99
COVID-19
93
NCDs
93
Conflict
59
Planetary Health
49
Refugee
44
Caregiver
43
Ebola
40
Rapid Response
36
Global Health Education
32
Pharmacy
27
Polio
14
Natural Hazards
10
Health Financing Toolbox
10
Cholera
8
Social Ethics
5
Specific Hazards
3
Zika
3
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
What countries need: Investments needed for 2010 targets
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
Today, the World Health Organization (WHO) is advancing the global fight against acute malnutrition in children under 5 with the launch of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition). This milestone is a crucial response to the persistent...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
